Literature DB >> 16402926

Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.

M Hoshiro1, Y Ohno, H Masaki, H Iwase, N Aoki.   

Abstract

OBJECTIVE: To further analyse the significance and mutual relationship of thyroid function-linked alterations in cortisol metabolism that have been separately and variously reported. PATIENTS AND MEASUREMENTS: Twenty-four-hour urine samples from 21 patients with hyperthyroidism (Graves' disease), 16 patients with hypothyroidism (Hashimoto's thyroiditis), 21 healthy age- and sex-matched controls for hyperthyroidism, and 16 healthy age- and sex-matched controls for hypothyroidism were evaluated for 6beta-hydroxycortisol (6beta-OHF), tetrahydrocortisol (THF), tetrahydrocortisone (THE), allo-tetrahydrocortisol (allo-THF), urinary free cortisol (UFF), urinary free cortisone (UFE) and 17-hydroxycorticosteroid (17-OHCS).
RESULTS: Urinary 17-OHCS, THE and allo-THF levels increased considerably in hyperthyroid patients compared to the controls, while UFF and THF showed no difference between the two groups. Urinary 6beta-OHF was significantly lower in the hyperthyroid patients than in the controls. Both the urinary allo-THF + THF/THE and the UFF/UFE ratios were significantly lower in the hyperthyroid patients than in the controls, whereas only the former was significantly higher in the hypothyroid patients than in the controls. The urinary allo-THF/THF ratio was significantly higher in the hyperthyroid patients and significantly lower in the hypothyroid patients than in the controls. In an analysis of pooled subjects including all groups (n = 64), free T4 levels correlated negatively (P < 0.0001) with the urinary allo-THF + THF/THE ratio but not with the UFF/UFE ratio. The serum levels of free T4 correlated positively (P < 0.0001) with the urinary allo-THF/THF ratio.
CONCLUSION: The thyroid hormones seem to affect the total 11beta-HSD activity (allo-THF + THF/THE) more strongly than the renal 11beta-HSD2 activity (UFF/UFE). 5alpha-reductase activity (allo-THF/THF) is also enhanced in hyperthyroidism, while the reduction of urinary 6beta-OHF in hyperthyroidism might be a secondary effect of the altered activity of the total 11beta-HSD and 5alpha-reductase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402926     DOI: 10.1111/j.1365-2265.2005.02412.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

Review 1.  Influence of maternal thyroid hormones during gestation on fetal brain development.

Authors:  N K Moog; S Entringer; C Heim; P D Wadhwa; N Kathmann; C Buss
Journal:  Neuroscience       Date:  2015-10-03       Impact factor: 3.590

2.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

Review 3.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

4.  Adrenocortical reserves in hyperthyroidism.

Authors:  Kemal Agbaht; Sevim Gullu
Journal:  Endocrine       Date:  2013-03-27       Impact factor: 3.633

5.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

6.  Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.

Authors:  Johanna Melin; Zinnia P Parra-Guillen; Niklas Hartung; Wilhelm Huisinga; Richard J Ross; Martin J Whitaker; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

7.  Relative Adrenocortical Insufficiency Following Radioactive Iodine Therapy for Graves' Disease: A Report of Two Cases.

Authors:  Hanxin Zhao; Yu Ruan
Journal:  Int J Gen Med       Date:  2021-05-03

8.  More, less or both?

Authors:  Ilias Attaye; Merel van Andel; Albertus Jozef Kooter
Journal:  BMJ Case Rep       Date:  2018-03-05

9.  Prolactin-Producing Pituitary Carcinoma, Hypopituitarism, and Graves' Disease-Report of a Challenging Case and Literature Review.

Authors:  Rita Bettencourt-Silva; Josué Pereira; Sandra Belo; Daniela Magalhães; Joana Queirós; Davide Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-06       Impact factor: 5.555

10.  Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.

Authors:  Ehab S Eldesoky; Sherif I Kamel; Ahlam M Farghaly; Madiha Y Bakheet; Mohsen A Hedaya; Jean-Pascal Siest
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.